DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dljh6t/psoriasis) has announced the addition of the "Psoriasis - Pipeline Review, H2 2013" report to their offering.
'Psoriasis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Psoriasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Psoriasis.
- A snapshot of the global therapeutic scenario for Psoriasis.
- A review of the Psoriasis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Psoriasis pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Johnson & Johnson
Boehringer Ingelheim GmbH
Valeant Pharmaceuticals International
Antares Pharma, Inc.
Echo Therapeutics, Inc.
Stiefel Laboratories, Inc.
Piramal Healthcare Limited
Isotechnika Pharma Inc.
Dr. Reddy's Laboratories Limited
LEO Pharma A/S
Ono Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Limited
Cell Therapeutics, Inc.
and many more.....
For more information visit http://www.researchandmarkets.com/research/dljh6t/psoriasis
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.